...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Hypoglycemic Action of Sulfonylureas in Patients with Diabetes Mellitus
【24h】

Hypoglycemic Action of Sulfonylureas in Patients with Diabetes Mellitus

机译:磺脲类药物在糖尿病患者中的降血糖作用

获取原文
           

摘要

Recent reports from Germany have stimulated renewed interest in an action of certain sulfonamide compounds on the blood sugar in diabetes mellitus. A class of sulfonamide compounds termed sulfonylureas have been shown to have a hypoglycemic effect and to eliminate the need for exogenous insulin in many adults with diabetes mellitus. This effect is believed to be due to an action of sulfonylureas as inhibitors of an enzyme responsible for the destruction of insulin (insulinase). Sulfonylureas have been most effective in adults with mild diabetes acquired late in life. Diabetes in childhood and adolescence, or in those in whom it has persisted for many years, have shown little or no response to the administration of sulfonylureas. The usefulness of these compounds in the treatment of patients with diabetes mellitus has not been determined and must be ascertained by careful clinical trials.
机译:德国最近的报道激发了人们对某些磺酰胺类化合物对糖尿病血糖的作用的兴趣。在许多患有糖尿病的成年人中,一类称为磺酰脲类的磺酰胺化合物已显示出降血糖作用,并消除了对外源胰岛素的需要。认为该作用归因于磺酰脲类作为负责破坏胰岛素的酶(胰岛素酶)的抑制剂的作用。磺脲类药物在生命后期获得轻度糖尿病的成年人中最有效。儿童期和青春期的糖尿病,或者持续多年的糖尿病,对磺酰脲类药物的治疗几乎没有反应。这些化合物在糖尿病患者治疗中的用途尚未确定,必须通过仔细的临床试验确定。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号